Citation

Chary R, Sneha L, Vishnukanth G, Manju R. Adv. Respir. Med. 2020; 88(2): 157-159.

Copyright

(Copyright © 2020, Via Medica)

DOI

10.5603/ARM.2020.0091

PMID

32383469

Abstract

INTRODUCTION: Metallic mercury poisoning through intravenous injection is rare, especially as part of a suicide attempt. Diagnosis and treatment of the disease are challenging as clinical features are not specific.
MATERIAL AND METODS: A 41-year-old male presented with dyspnea, fatigue, loss of weight, and loss of appetite over two months. Routine radiological examination by chest X-ray and CT showed randomly distributed high density opacities with Hounsfield units (HU) around 500 HU all over the body. The diagnosis was then confirmed with a urinary mercury concentration of > 1000 mcg/24 h.
RESULTS: The patient's clinical condition was getting worse in spite of chelation therapy and hemodialysis. The patient eventually died because of respiratory failure.
CONCLUSION: Early diagnosis and appropriate treatment are critical for intravenous mercury poisoning especially because there are no specific signs or symptoms. There should be a high level of suspicion in drug abusers. Treatment should involve the combined use of chelating agents and other treatments such as hemodialysis and plasma exchange in advanced clinical settings.

Language: en

Keywords

Humans; Adult; Male; Fatal Outcome; Pulmonary Embolism; Respiratory Insufficiency; drug abuse; Chelating Agents; Mercury Poisoning; mercury poisoning; chelating agents; high density opacities